Swiss Market Community
Our community narratives are driven by numbers and valuation.
Swiss Investing Ideas
Global Weekly Picks
Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.
The academically fascinating Tesla
Roche Holding AG To Benefit From Strong Drug Pipeline In 2027 And Beyond
About Roche Holding AG Roche is one of the world’s largest pharmaceutical companies, with a market capitalization of approximately CHF 300 billion (USD 380bn). The company operates through two primary divisions: •Roche Pharmaceuticals: A global leader in biotechnology and the leading provider of treatments for cancer.Read more
Nestlé: Quality Stock, Attractive Price—But Proceed with Caution
☕ Business Overview Founded in 1866, Nestlé began as a pioneer in infant nutrition and has grown into the world’s largest food and beverage company. Initially focused on powdered milk and chocolate, the company has strategically reshaped its portfolio through innovation in health, wellness and divestment from slower-growth categories.Read more
Roche Holding will see a 4.2576% revenue growth shaking the market
Valuation ### **Analyse der Roche Jahreszahlen 2024: Wachstum setzt sich fort, Herausforderungen bleiben_20250130 #### Zusammenfassung der Ergebnisse Roche hat für das Jahr 2024 ein solides Wachstum von 7 % auf 60,5 Mrd. CHF erzielt, was die Erwartungen leicht übertroffen hat.Read more
Biotech longerterm bet
211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.Read more
Cosmo Pharmaceuticals Announces Strong Full Year 2024 Revenue and Cash and Provides Business and Pipeline Updates
Catalysts Preliminary Unaudited Revenue and Cash Revenue: €266.8 million, representing a year-on-year increase of 188% compared to €92.8 million in 2023. This includes significant project-based revenues from GI Genius™ and Winlevi® of €190.2 million.Read more
High-value Healthcare And Electric Vehicles Will Transform Future Markets
Key Takeaways Expansion in high-value healthcare and electric vehicle sectors is driving improved product mix, supporting revenue growth and stronger profit margins. Transformation initiatives and investments in automation are boosting productivity, operational efficiency, and future earnings potential.Read more
Increasing European Costs And Digital Lags Will Erode Value
Key Takeaways Rising compliance costs, demographic headwinds, and inconsistent project margins threaten long-term revenue growth, margin improvement, and earnings stability. Slow digital adoption and heavy exposure to complex projects increase risks of market share loss, cash flow instability, and financial underperformance.Read more
Switzerland And EU Reforms Will Transform Energy Infrastructure
Key Takeaways Regulatory changes and favorable policies are creating new growth avenues in decarbonization, grid modernization, and energy renovation, supporting sustained revenue and margin expansion. Smart meter deployment, digital innovation, operational efficiencies, and strategic investments in renewables and acquisitions are strengthening profitability and future earnings stability.Read more
Interest Rate Cuts And European Competition Will Pressure Profits Yet AI Investments Will Sustain Performance
Key Takeaways Anticipated revenue pressure from decreased interest rates and limited growth in competitive trading environments may constrain Swissquote's net margins and revenue growth. Planned technology investments and rising compliance costs could increase expenses, challenging Swissquote's profitability goals in a highly competitive market.Read more
